END-STAGE RENAL DISEASE IN MISURATA

The prevalence of End-stage renal disease (ESRD) has been continuously increasing in most of countries. ESRDrequiring renal replacement therapy poses a tremendous burden on health care budgets. Unfortunately, there areno studies on the epidemiology and prevalence of ESRD in Misurata city, hence, our study was conducted toassess the prevalence, etiology and risk factors for ESRD patients on haemodialysis (HD) at Misurata city duringthe year 2005. This is a descriptive study conducted retrospectively by reviewing files of all patients attendinghaemodialysis unit at Misurata Central Hospital during 2005. The total number of ESRD patients undergoinghaemodialysis from January 2005 to December of the same year was 70 patients. Their mean age was 36.4±17.7years, and of median 37.7 (range 3-69). The male constituted 55.7% while female patients were 44.3% with maleto female ratio of 1.25:1. The estimated prevalence of ESRD was 34.71% patients per 100.000 populations. Themost common causes of ESRD were diabetes mellitus in 28.5% and hypertension in 17.1% followed in order byundetermined causes in 15.7%, glomerulonephritis in 14.3%, chronic pyelonephritis in 8.6%, drug nephrotoxicity in 5.7%, other less common causes like obstructive uropathy, polycystic kidney disease, gout and IgAnephropathy also was reported in our study. The most common causes of ESRD were found to be DM and HTN,affecting young- age population. This suggests that we need to improve our health care system and implementation of effective reno-protective strategies.